| Parallel G-quadruplex structures increase cellular uptake and cytotoxicity of 5-fluoro-2′-deoxyuridine oligomers in 5-fluorouracil resistant cells A Clua, C Fàbrega, J García-Chica, S Grijalvo, R Eritja Molecules 26 (6), 1741, 2021 | 7 | 2021 |
| Oligonucleotides carrying nucleoside antimetabolites as potential prodrugs C Fàbrega, A Clua, R Eritja, A Aviñó Current Medicinal Chemistry 30 (11), 1304-1319, 2023 | 4 | 2023 |
| Evaluation of floxuridine oligonucleotide conjugates carrying potential enhancers of cellular uptake A Aviñó, A Clua, MJ Bleda, R Eritja, C Fàbrega International Journal of Molecular Sciences 22 (11), 5678, 2021 | 4 | 2021 |
| Tuning G-quadruplex nanostructures with lipids. Towards designing hybrid scaffolds for oligonucleotide delivery S Grijalvo, A Clua, M Eres, R Gargallo, R Eritja International Journal of Molecular Sciences 22 (1), 121, 2020 | 4 | 2020 |
| Properties of Parallel Tetramolecular G-Quadruplex Carrying N-Acetylgalactosamine as Potential Enhancer for Oligonucleotide Delivery to Hepatocytes A Clua, S Grijalvo, N Erande, S Gupta, K Yucius, R Gargallo, S Mazzini, ... Molecules 27 (12), 3944, 2022 | 1 | 2022 |
| Correction: Clua et al. Properties of Parallel Tetramolecular G-Quadruplex Carrying N-Acetylgalactosamine as Potential Enhancer for Oligonucleotide Delivery to Hepatocytes … A Clua, S Grijalvo, N Erande, S Gupta, K Yucius, R Gargallo, S Mazzini, ... Molecules 28 (1), 98, 2022 | | 2022 |
| Direct detection of SARS-CoV-2 RNA using triple helix structures A Domínguez, A Clua, N Navarro, C Fàbrega, R Eritja Casadellà, A Aviñó | | 2022 |
| Customized DNA Origami for delivery of therapeutic oligonucleotides N Navarro, A Aviñó, A Clua, A Domínguez, R Eritja Casadellà, C Fàbrega | | 2022 |
| Nanostructures for delivery of therapeutic oligonucleotides R Eritja Casadellà, C Fàbrega, AF Jorge, A Aviñó, A Clua, N Navarro, ... | | 2022 |
| G-quadruplex nanoestructure with N-acetilgalactosamine as potential enhancer for oligonucleotide drug delivery A Clua, S Grijalvo, N Erande, S Gupta, K Yucius, R Gargallo, S Mazzini, ... | | 2022 |
| Therapeutic Oligonucleotides and Nanomedicine R Eritja Casadellà, A Aviñó, C Fàbrega, A Clua, A Domínguez, N Navarro, ... | | 2022 |
| DNA-lipid conjugates as potential cellular uptake enhancers S Serantes, C Fábrega, A Aviñó, A Clua, N Navarro, A Domínguez, ... | | 2022 |
| Introducció d'agents quimioterapeutics en forma de prodroga mitjançant oligonucleòtids A Clua, A Aviñó, C Fàbrega, S Grijalvo, N Navarro, R Eritja Casadellà | | 2022 |
| Developing DNA nanostructures for drug delivery C Fàbrega, AF Jorge, A Aviñó, S Grijalvo, A Clua, N Navarro, ... | | 2022 |
| Parallel G-quadruplex, small nanostructures with enhanced cellular uptake properties A Clua, S Grijalvo, C Fàbrega, A Aviñó, N Erande, R Gargallo, S Mazzini, ... | | 2021 |
carme fabregaIQACVerified email at iqac.csic.es
